Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Letter by Zhang et al Regarding Article, "IMPROVE-DiCE, a 2-Part, Open-Label, Phase 2a Trial Evaluating the Safety and Effectiveness of Ninerafaxstat in Patients With Cardiometabolic Syndromes".

Created on 03 Nov 2026

Authors

Hongliang Zhang, Wence Shi, Yongjian Wu

Published in

Circulation. Volume 154. Issue 18. Pages e666-e667. Nov 03, 2026. Epub Nov 02, 2026.

PMID:
42970624
Bibliographic data and abstract were imported from PubMed on 03 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 7
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement